Xtant Medical Holdings, Inc. (XTNT) stock
XTNTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026Score 9/3075% below fair value
$0.28−0.00 (-0.94%)
Close on Nov 12, 2026Market cap $38.62MP/E –Yield –
Xtant Medical profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Xtant Medical's profit margin for the twelve months ending Jun 30, 2026 was -10.2%. For fiscal 2025 it was 3.7%, against -14.0% the year before. The highest annual figure on record is 3.7% in fiscal 2025.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3.7% | +17.7 |
| FY2024 | Dec 31, 2024 | -14.0% | −14.7 |
| FY2023 | Dec 31, 2023 | 0.7% | +15.4 |
| FY2022 | Dec 31, 2022 | -14.6% | −5.9 |
| FY2021 | Dec 31, 2021 | -8.8% | +4.4 |
| FY2020 | Dec 31, 2020 | -13.2% | −0.5 |
| FY2019 | Dec 31, 2019 | -12.7% | +84.4 |
| FY2018 | Dec 31, 2018 | -97.1% | −33.6 |
| FY2017 | Dec 31, 2017 | -63.4% | −41.8 |
| FY2016 | Dec 31, 2016 | -21.7% | −18.0 |
| FY2015 | Dec 31, 2015 | -3.7% | +26.1 |
| FY2014 | Dec 31, 2014 | -29.7% | +8.6 |
| FY2013 | Dec 31, 2013 | -38.4% | −15.0 |
| FY2012 | Dec 31, 2012 | -23.4% | −13.4 |
| FY2011 | Dec 31, 2011 | -10.0% | +116.3 |
| FY2010 | Dec 31, 2010 | -126.3% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -40.9% | −50.9 |
| Q1 FY2026 | Mar 31, 2026 | -14.8% | −15.0 |
| Q4 FY2025 | Dec 31, 2025 | 0.2% | +10.2 |
| Q3 FY2025 | Sep 30, 2025 | 3.9% | +21.9 |
| Q2 FY2025 | Jun 30, 2025 | 10.0% | +22.9 |
| Q1 FY2025 | Mar 31, 2025 | 0.2% | +16.0 |
| Q4 FY2024 | Dec 31, 2024 | -10.0% | +5.3 |
| Q3 FY2024 | Sep 30, 2024 | -18.0% | −54.9 |
| Q2 FY2024 | Jun 30, 2024 | -12.9% | −2.1 |
| Q1 FY2024 | Mar 31, 2024 | -15.8% | −4.2 |
| Q4 FY2023 | Dec 31, 2023 | -15.3% | −0.8 |
| Q3 FY2023 | Sep 30, 2023 | 36.9% | +53.2 |
| Q2 FY2023 | Jun 30, 2023 | -10.8% | +0.4 |
| Q1 FY2023 | Mar 31, 2023 | -11.6% | +5.5 |
| Q4 FY2022 | Dec 31, 2022 | -14.5% | +1.9 |
| Q3 FY2022 | Sep 30, 2022 | -16.3% | −3.2 |
| Q2 FY2022 | Jun 30, 2022 | -11.2% | −6.3 |
| Q1 FY2022 | Mar 31, 2022 | -17.1% | −16.8 |
| Q4 FY2021 | Dec 31, 2021 | -16.3% | −11.3 |
| Q3 FY2021 | Sep 30, 2021 | -13.1% | −3.4 |
| Q2 FY2021 | Jun 30, 2021 | -4.9% | +18.5 |
| Q1 FY2021 | Mar 31, 2021 | -0.2% | +16.6 |
| Q4 FY2020 | Dec 31, 2020 | -5.0% | +4.4 |
| Q3 FY2020 | Sep 30, 2020 | -9.7% | +2.2 |
| Q2 FY2020 | Jun 30, 2020 | -23.4% | −10.7 |
| Q1 FY2020 | Mar 31, 2020 | -16.9% | −0.1 |
| Q4 FY2019 | Dec 31, 2019 | -9.5% | +301.0 |
| Q3 FY2019 | Sep 30, 2019 | -12.0% | +6.3 |
| Q2 FY2019 | Jun 30, 2019 | -12.7% | +14.0 |
| Q1 FY2019 | Mar 31, 2019 | -16.7% | +12.6 |
| Q4 FY2018 | Dec 31, 2018 | -310.4% | −163.4 |
| Q3 FY2018 | Sep 30, 2018 | -18.3% | +24.8 |
| Q2 FY2018 | Jun 30, 2018 | -26.7% | +18.6 |
| Q1 FY2018 | Mar 31, 2018 | -29.3% | −3.1 |
| Q4 FY2017 | Dec 31, 2017 | -147.0% | −128.5 |
| Q3 FY2017 | Sep 30, 2017 | -43.0% | −21.8 |
| Q2 FY2017 | Jun 30, 2017 | -45.3% | – |
| Q1 FY2017 | Mar 31, 2017 | -26.2% | – |
| Q4 FY2016 | Dec 31, 2016 | -18.5% | – |
| Q3 FY2016 | Sep 30, 2016 | -21.2% | – |
See a number that looks wrong?